AQST

AQST

USD

Aquestive Therapeutics Inc. Common Stock

$6.040-0.370 (-5.772%)

السعر في الوقت الحقيقي

Healthcare
Drug Manufacturers - Specialty & Generic
الولايات المتحدة

مخطط الأسعار

Loading Chart...

المقاييس الرئيسية

مقاييس السوق
أساسيات الشركة
إحصاءات التداول

مقاييس السوق

الافتتاح

$6.410

الأعلى

$6.410

الأدنى

$5.790

الحجم

3.85M

أساسيات الشركة

القيمة السوقية

736.9M

الصناعة

Drug Manufacturers - Specialty & Generic

البلد

United States

إحصاءات التداول

متوسط الحجم

3.10M

البورصة

NGM

العملة

USD

نطاق 52 أسبوعاً

الأدنى $2.12الحالي $6.040الأعلى $7.55

أخبار ذات صلة

GlobeNewswire

Aquestive Therapeutics Announces Leadership Expansion to Support Growth

Changes strategically aligned to support planned launch of Anaphylm™ (dibutepinephrine) Sublingual Film, if approved by the FDA, and to accelerate the Company's ongoing development initiatives Matthew Davis, M.D.,

عرض المزيد
Aquestive Therapeutics Announces Leadership Expansion to Support Growth
GlobeNewswire

Aquestive Therapeutics to Participate in a Fireside Chat Hosted by Piper Sandler

WARREN, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients'

عرض المزيد
Aquestive Therapeutics to Participate in a Fireside Chat Hosted by Piper Sandler
GlobeNewswire

Aquestive Therapeutics to Attend 2025 ACAAI Annual Meeting

WARREN, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients'

عرض المزيد
Aquestive Therapeutics to Attend 2025 ACAAI Annual Meeting
GlobeNewswire

Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ET

WARREN, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients'

عرض المزيد
Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ET

ابق على اطلاع

تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.